The Best CBD Oil Stocks to Buy for 2020

Several applications of cannabis are forming entire industries of their own - from medicinal use, to beverages, to edibles. The CBD industry has a hand in all of these.

That's why it's expected to grow to $22 billion. And our best CBD oil stocks to buy are taking the lion's share of that.

Otherwise known as cannabidiol, CBD is a non-psychoactive hemp compound. It's noted for several health benefits, without the "high" typically associated with marijuana. And it's a huge market because CBD can be consumed in all the same ways as its hallucinogenic counterpart.

CBD can be infused with drinks, foods, soaps, and much more to aid sleep. The compound has been used to support sleep, lower anxiety, and decrease pain from chronic illnesses.

For more on cannabis stocks, visit the National Institute for Cannabis Investors. It has all you need to know to start your cannabis investing journey. And it'll point you to the top cannabis and CBD stocks trading right now.

Our best cannabis stock picks for 2020 are notably in CBD products. So, without further ado, here are the top CBD oil stocks for 2020.

Beverages Infused with CBD Are Coming

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Canadian companies are scrambling to get food and beverages infused with CBD on the shelves sometime this month.

One to look at is Truss Beverage Co., which has a joint venture with Hexo Corp. (NYSE: HEXO) and Molson Coors Brewing Co. (NYSE: TAP), a subsidiary of Molson Coors Canada.

According to Beverage Daily, 80% of beverages that Truss produces are going to be infused with THC, CBD, or both, all with "low- to mid-level doses" of the products.

Truss itself says that it wants to be "one of the first on the playing field" as the cannabis drinkables market gets underway. Molson predicts that, in the medium term, the cannabis beverage market could be valued between CA$1.5 billion and CA$3 billion, the equivalent of $1.14 billion to $2.27 billion in the United States.

Also by next year, Canopy Growth Corp. (NYSE: CGC) has plans to launch CBD-infused sparkling water and a psychoactive ginger ale. These are just two of the company's 16 new infused products revealed at a tasting event in Ontario in the Fall.

Vivien Azer, a noted cannabis analyst from Cowen, spoke with Yahoo Finance Canada last month about these new products. Azer predicts that these new products will mimic the appearance and taste of established sodas, alcoholic drinks, and sports drinks in the early stages.

Diverse consumer preferences show there is plenty of room in this space. But those who get in early will have the upper hand - as will their shareholders.

America's 1% Are Converging on the Next "Gold Rush"

The Fortune 500, big investment firms, and the Wall Street elite are all pouring billions into a new agribusiness market.

It's an investment strategy that's already worked for them before - for example...

Vanguard, Credit Suisse, and RBC were behind an IPO in this industry that shot up 659% in under one year...

Deutsche Bank and UBS were behind the scenes of a 641% windfall...

And Goldman Sachs, Black Rock, and Morgan Stanley lined their pockets with a whopping 3,813% profit...

But the biggest gains are yet to come. As medical research in this area trucks on, this could become a $1 trillion global industry. Individual investors could become millionaires practically overnight.

I know the numbers are big, but the research backs it up.

What's more, we've picked three stocks in this industry with the biggest upside potential.

Just click here to see for yourself...

Follow Money Morning on Facebook and Twitter.